Posted by: APO | 15 April 2019

Joint Press Release: Europe-Africa partnership spearheads development of next-generation antimalarial drug

The European & Developing Countries Clinical Trials Partnership (EDCTP) ( grants €10 million over five years to “WANECAM 2” a unique collaboration between antimalarial drug researchers in Africa and Europe from ten academic institutions, a pharmaceutical company, Novartis, and a not-for-profit product development partnership (PDP), Medicines for Malaria Venture; the grant will… Read more on


%d bloggers like this: